Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$6.57
-0.33-4.78%
At close: -
$6.63
0.060.91%
After Hours: 6:40 PM EDT
Comments
Loading...
WAVE Life Sciences Analyst Ratings and Price Targets | NASDAQ:WVE | Benzinga
WAVE Life Sciences Ltd has a consensus price target of $18.87 based on the ratings of 15 analysts. The high is $36 issued by Truist Securities on November 12, 2024. The low is $7 issued by SVB Leerink on December 14, 2022. The 3 most-recent analyst ratings were released by Raymond James, Cantor Fitzgerald, and HC Wainwright & Co. on June 11, 2025, April 29, 2025, and March 26, 2025, respectively. With an average price target of $15.33 between Raymond James, Cantor Fitzgerald, and HC Wainwright & Co., there's an implied 131.27% upside for WAVE Life Sciences Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Raymond James
Cantor Fitzgerald
HC Wainwright & Co.
Jefferies
Mizuho
1calculated from analyst ratings
Analyst Ratings for WAVE Life Sciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/11/2025 | Buy Now | 111.16% | Raymond James | Michael Freeman17% | → $14 | Assumes | → Outperform | Get Alert |
| 04/29/2025 | Buy Now | 50.83% | Cantor Fitzgerald | Steven Seedhouse57% | → $10 | Initiates | → Overweight | Get Alert |
| 03/26/2025 | Buy Now | 231.83% | HC Wainwright & Co. | Andrew Fein61% | $22 → $22 | Reiterates | Buy → Buy | Get Alert |
| 03/05/2025 | Buy Now | 231.83% | HC Wainwright & Co. | Andrew Fein61% | $22 → $22 | Reiterates | Buy → Buy | Get Alert |
| 02/25/2025 | Buy Now | 292.16% | Jefferies | Roger Song36% | → $26 | Initiates | → Buy | Get Alert |
| 11/21/2024 | Buy Now | 231.83% | Mizuho | Salim Syed44% | $19 → $22 | Maintains | Outperform | Get Alert |
| 11/13/2024 | Buy Now | 231.83% | HC Wainwright & Co. | Andrew Fein61% | $22 → $22 | Reiterates | Buy → Buy | Get Alert |
| 11/12/2024 | Buy Now | 442.99% | Truist Securities | Joon Lee77% | $17 → $36 | Maintains | Buy | Get Alert |
| 11/04/2024 | Buy Now | 231.83% | B. Riley Securities | Madison El-Saadi28% | $19 → $22 | Maintains | Buy | Get Alert |
| 10/31/2024 | Buy Now | 231.83% | HC Wainwright & Co. | Andrew Fein61% | $22 → $22 | Reiterates | Buy → Buy | Get Alert |
| 10/21/2024 | Buy Now | 126.24% | RBC Capital | Luca Issi45% | $7 → $15 | Maintains | Sector Perform | Get Alert |
| 10/17/2024 | Buy Now | 156.41% | JP Morgan | Eric Joseph43% | $13 → $17 | Maintains | Overweight | Get Alert |
| 10/17/2024 | Buy Now | 231.83% | HC Wainwright & Co. | Andrew Fein61% | $22 → $22 | Reiterates | Buy → Buy | Get Alert |
| 10/16/2024 | Buy Now | 231.83% | Raymond James | Steven Seedhouse57% | $13 → $22 | Upgrade | Outperform → Strong Buy | Get Alert |
| 10/16/2024 | Buy Now | 231.83% | Wells Fargo | Tiago Fauth47% | $11 → $22 | Maintains | Overweight | Get Alert |
| 10/16/2024 | Buy Now | 231.83% | Leerink Partners | Mani Foroohar50% | $20 → $22 | Maintains | Outperform | Get Alert |
| 10/04/2024 | Buy Now | 5.58% | RBC Capital | Luca Issi45% | $5 → $7 | Maintains | Sector Perform | Get Alert |
| 10/03/2024 | Buy Now | 186.58% | B. Riley Securities | Madison El-Saadi28% | $11 → $19 | Maintains | Buy | Get Alert |
| 09/27/2024 | Buy Now | 96.08% | JP Morgan | Eric Joseph43% | $10 → $13 | Reinstates | Overweight → Overweight | Get Alert |
| 09/25/2024 | Buy Now | 141.33% | Jones Trading | Catherine Novack32% | $12 → $16 | Maintains | Buy | Get Alert |
| 09/25/2024 | Buy Now | 231.83% | HC Wainwright & Co. | Andrew Fein61% | $15 → $22 | Maintains | Buy | Get Alert |
| 09/19/2024 | Buy Now | 65.91% | B. Riley Securities | Madison El-Saadi28% | → $11 | Initiates | → Buy | Get Alert |
| 09/09/2024 | Buy Now | 50.83% | JP Morgan | — | → $10 | Initiates | → Overweight | Get Alert |
| 08/09/2024 | Buy Now | 81% | Jones Trading | Catherine Novack32% | → $12 | Initiates | → Buy | Get Alert |
| 06/26/2024 | Buy Now | 126.24% | HC Wainwright & Co. | Andrew Fein61% | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
| 06/25/2024 | Buy Now | 186.58% | Mizuho | Salim Syed44% | $19 → $19 | Reiterates | Outperform → Outperform | Get Alert |
| 05/15/2024 | Buy Now | 65.91% | Wells Fargo | Tiago Fauth47% | → $11 | Initiates | → Overweight | Get Alert |
| 04/01/2024 | Buy Now | 156.41% | Truist Securities | Joon Lee77% | $17 → $17 | Reiterates | Buy → Buy | Get Alert |
| 03/12/2024 | Buy Now | 186.58% | Mizuho | Salim Syed44% | $10 → $19 | Maintains | Buy | Get Alert |
| 03/07/2024 | Buy Now | -24.59% | RBC Capital | Luca Issi45% | $5 → $5 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 03/07/2024 | Buy Now | 126.24% | HC Wainwright & Co. | Andrew Fein61% | $8 → $15 | Maintains | Buy | Get Alert |
| 12/19/2023 | Buy Now | 81% | Leerink Partners | Mani Foroohar50% | → $12 | Upgrade | Market Perform → Outperform | Get Alert |
| 08/04/2023 | Buy Now | 20.66% | HC Wainwright & Co. | Andrew Fein61% | → $8 | Reiterates | Buy → Buy | Get Alert |
| 07/05/2023 | Buy Now | 5.58% | Raymond James | Steven Seedhouse57% | → $7 | Initiates | → Outperform | Get Alert |
| 06/23/2023 | Buy Now | 156.41% | Truist Securities | Joon Lee77% | → $17 | Reiterates | Buy → Buy | Get Alert |
| 05/24/2023 | Buy Now | 50.83% | Mizuho | Salim Syed44% | $13 → $10 | Maintains | Buy | Get Alert |
| 05/24/2023 | Buy Now | 20.66% | HC Wainwright & Co. | Andrew Fein61% | → $8 | Reiterates | Buy → Buy | Get Alert |
| 05/04/2023 | Buy Now | -24.59% | RBC Capital | Luca Issi45% | → $5 | Reiterates | → Sector Perform | Get Alert |
| 04/14/2023 | Buy Now | 96.08% | Mizuho | Salim Syed44% | → $13 | Reiterates | → Buy | Get Alert |
| 03/23/2023 | Buy Now | 20.66% | HC Wainwright & Co. | Andrew Fein61% | → $8 | Reiterates | → Buy | Get Alert |
| 12/14/2022 | Buy Now | 5.58% | SVB Leerink | Mani Foroohar50% | $2 → $7 | Maintains | Market Perform | Get Alert |
| 11/11/2022 | Buy Now | -24.59% | RBC Capital | Luca Issi45% | $8 → $5 | Maintains | Sector Perform | Get Alert |
FAQ
What is the target price for WAVE Life Sciences (WVE) stock?
The latest price target for WAVE Life Sciences (NASDAQ:WVE) was reported by Raymond James on June 11, 2025. The analyst firm set a price target for $14.00 expecting WVE to rise to within 12 months (a possible 111.16% upside). 26 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for WAVE Life Sciences (WVE)?
The latest analyst rating for WAVE Life Sciences (NASDAQ:WVE) was provided by Raymond James, and WAVE Life Sciences their outperform rating.
When was the last upgrade for WAVE Life Sciences (WVE)?
The last upgrade for WAVE Life Sciences Ltd happened on October 16, 2024 when Raymond James raised their price target to $22. Raymond James previously had an outperform for WAVE Life Sciences Ltd.
When was the last downgrade for WAVE Life Sciences (WVE)?
There is no last downgrade for WAVE Life Sciences.
When is the next analyst rating going to be posted or updated for WAVE Life Sciences (WVE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of WAVE Life Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for WAVE Life Sciences was filed on June 11, 2025 so you should expect the next rating to be made available sometime around June 11, 2026.
Is the Analyst Rating WAVE Life Sciences (WVE) correct?
While ratings are subjective and will change, the latest WAVE Life Sciences (WVE) rating was a with a price target of $0.00 to $14.00. The current price WAVE Life Sciences (WVE) is trading at is $6.63, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
